SCHEMBL3985463

SCHEMBL3985463

CCOC(=O)c1[nH]c2ccc(O)cc2c1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.71
ALDH1A1 P00352 5/20 0.71
HPGD P15428 4/20 0.71
MAPT P10636 3/20 0.71
NPC1 O15118 2/20 0.71
RAB9A P51151 2/20 0.71
GAA P10253 4/20 0.66
HSD17B10 Q99714 3/20 0.59
LMNA P02545 2/20 0.59
MEN1 O00255 1/20 0.59
MAPK10 P53779 1/20 0.59
KMT2A Q03164 1/20 0.59
TP53 P04637 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
ALOX5 P09917 10/20 0.56
HCRTR1 O43613 1/20 0.56
HTT P42858 1/20 0.52
GABRP O00591 1/20 0.51
GABRD O14764 1/20 0.51
GABRA1 P14867 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3988373 0.95 KDM4E (0.68) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL1121564 0.88 KDM4E (0.59) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL7688090 0.87 ALDH1A1 (0.74) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL3990672 0.86 KDM4E (0.58) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL18531909 0.86 GAA (0.63) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL6983821 0.85 HCRTR1 (0.76) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL16732481 0.85 KDM4E (0.71) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL3986203 0.85 ALDH1A1 (0.55) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL3283431 0.84 ALDH1A1 (0.69) KDM4EALDH1A1HPGDMAPTNPC1
SCHEMBL4077176 0.84 ALDH1A1 (0.69) KDM4EALDH1A1HPGDMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125397-A1 PREPARATION METHOD FOR AROMATIC RING DERIVATIVE FOR IMMUNE REGULATION 上海济煜医药科技有限公司 2023-07-06 WO disclosed
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands KARO BIO AB (SE) 2009-09-17 US disclosed
EP-2035377-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2009-03-18 EP disclosed
WO-2007134864-A1 INDOLE DERIVATIVES AND THEIR USE AS THYROID RECEPTOR LIGANDS KARO BIO AB (SE) 2007-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233979-A1 Indole Derivatives and Their Use as Thyroid Receptor Ligands TSHR, TRHR, THRA KDM4E 1169/4885ALDH1A1 1439/4885HPGD 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.